The role of miR-26 in tumors and normal tissues (Review)

Oncology Letters

Volumn 2, Issue 6, 2011, Pages 1019-1023

  Gao, Jie ^a   Liu, Qing Guang ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

miR 26; Review; Tumorigenesis growth and development

Indexed keywords

MICRORNA; MICRORNA 26; UNCLASSIFIED DRUG;

CARCINOGENESIS; CELL DIFFERENTIATION; DOWN REGULATION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; REVIEW; RNA STRUCTURE; RNA SYNTHESIS; TISSUE GROWTH; UPREGULATION;

EID: 80052731546     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.413     Document Type: Review

References (34)

1. Liu X, Chen Z, Yu J and Zhou X: MicroRNA profiling and head and neck cancer. Comp Funct Genomics 837514: 1-11, 2009.
2. Lewis BP, Shih I, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell 115: 787-798, 2003.
3. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005.
4. Xiaohui X, Jun L, Kulbokas EJ, et al: Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature 434: 338-345, 2005.
5. Williams AE: Functional aspects of animal microRNAs. Cell Mol Life Sci 65: 545-562, 2008.
6. Stefani G and Slack FJ: Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9: 219-230, 2008.
7. Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114, 2008.
8. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116: 281-297, 2004.
9. Bushati N and Cohen SM: microRNA functions. Annu Rev Cell Dev Biol 23: 175-205, 2007.
10. Chang TC and T Mendell J: microRNAs in vertebrate physio-logy and human disease. Annu Rev Genomics Hum Genet 8: 215-239, 2007.
11. Kloosterman WP and Plasterk RHA: The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450, 2006.
12. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
13. Tong AW and Nemunaitis J: Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 15: 341-355, 2008.
14. Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771, 2005.
15. Calin GA, Sevignani C, Dumitru CD, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad of Sci U S A 101: 2999-3004, 2004.
16. Muinos-Gimeno M, Montfort M, Bayes M, Estivill X and Espinosa-Parrilla Y: Design and evaluation of single-nucleotide polymorphisms in microRNA genomic regions for association studies in human disease. Eur J Hum Genet 18: 218-226, 2010.
17. Diederichs S and Haber DA: Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing. Cancer Res 66: 6097-6104, 2006.
18. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
19. Marilena V Iorio, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005.
20. Wang G, Zhang H, He H, et al: Up-regulation of microRNA in bladder tumor tissue is not common. Int Urol Nephrol 42: 95-102, 2009.
21. Maillot G, Lacroix-Triki M, Pierredon S, et al: Widespread estrogen-dependent repression of microRNAs in breast tumor cell growth. Cancer Res 69: 8332-8340, 2009.
22. Zhang B, Liu XX, He JR, et al: Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis 32: 2-9, 2010.
23. Yu T, Wang XY, Gong RG, et al: The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res 28: 64-73, 2009.
24. Visone R, Pallante P, Vecchione A, et al: Specific microRNA are downregulated in human thyroid anaplastic carcinomas. Oncogene 26: 7590-7595, 2007.
25. Ciarapica R, Russo G, Verginelli F, Donfrancesco A, Rota R and Giordano A: Deregulated expression of miR-26a and EZH2 in rhabdomyosarcoma. Cell Cycle 8: 172-175, 2009.
26. Sandrine S, Lars B and Thomas W: Repressing the repressor: a new mode of MYC action in lymphomagenesis. Cell Cycle 8: 556-559, 2009.
27. Kota J, Chivukula RR, O'Donnell KA, et al: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137: 1005-1017, 2009.
28. Ji J, Shi J, Budhu A, et al: MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361: 1437-1447, 2009.
29. Huse JT, Brennan C, Hambardzumyan D, et al: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes and Dev 23: 1327-1337, 2009.
30. Kim H, Huang W, Jiang X, Pennicooke B, Park PJ and Johnson MD: Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proc Natl Acad of Sci USA 107: 2183-2188, 2010.
31. Padgett KA, Lan RY, Leung PC, et al: Primary billiary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun 32: 246-253, 2009.
32. Rogler CE, LeVoci L, Ader T, Massimi A, Tchaikovskaya T, Norel R and Rogler LE: MicroRNA-23b cluster microRNA regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology 50: 575-584, 2009.
33. Itoh T, Nozawa Y and Akao Y: MicroRNA-141 and-200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem 284: 19272-19279, 2009.
34. Wong CF and Tellam RL: MicroRNA-26a targets the histone methyltransferase enhancer of Zeste homolog 2 during myo-genesis. J Biol Chem 283: 9836-9843, 2008.